The proposed research will focus on sickle (SS) red cell-endothelial interaction and related vasoocclusion using a combination of perfusion techniques and intravital observations. We will investigate the basis of abnormal red cell interaction with the endothelium in sickle cell disease by emphasizing the potential role of defined hemodynamic, cellular and humoral factors. Experiments are designed to accomplish the following objectives: 1. The role of hemodynamic factors in determining the sites and extent of adhesion with reference to the wall shear rates and microvascular adhesion sites and the effect of adhesion and red cell aggregation on hemodynamic parameters. 2. The role of von Willebrand factor (vWF), other adhesive proteins, and known receptors to these proteins in promotion and inhibition of sickle cell-endothelial interaction. 3. To define the basis for the observed differences in adhesion properties of density-defined classes of sickle cells. To differentiate the role of cellular rigidity (deoxygenation and MCHC) and membrane characteristics in adhesion of density defined SS cell classes. 3. To investigate the role of selected vasoactive stimuli in adhesion. Emphasis will be given to the role of substances which elicit multiple responses in the endothelium (e.g. , histamine, bradykinin, thrombin, etc) and thereby effect the vWF secretion, venular permeability as well as the vascular tone. Also, the effect of known smooth muscle agonists and relaxants will be evaluated. The results of the proposed protocol may provide better understanding of the potential role of adhesion in vasooclusive events in sickle cell disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL045931-02
Application #
3364997
Study Section
Special Emphasis Panel (SRC (OD))
Project Start
1990-09-30
Project End
1995-07-31
Budget Start
1991-08-01
Budget End
1992-07-31
Support Year
2
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Type
Schools of Medicine
DUNS #
009095365
City
Bronx
State
NY
Country
United States
Zip Code
10461
Kaul, Dhananjay K; Fabry, Mary E (2004) In vivo studies of sickle red blood cells. Microcirculation 11:153-65
Kaul, D K; Liu, X; Nagel, R L (2001) Ameliorating effects of fluorocarbon emulsion on sickle red blood cell-induced obstruction in an ex vivo vasculature. Blood 98:3128-31
Kaul, D K; Liu, X D; Fabry, M E et al. (2000) Impaired nitric oxide-mediated vasodilation in transgenic sickle mouse. Am J Physiol Heart Circ Physiol 278:H1799-806
Kaul, D K; Tsai, H M; Liu, X D et al. (2000) Monoclonal antibodies to alphaVbeta3 (7E3 and LM609) inhibit sickle red blood cell-endothelium interactions induced by platelet-activating factor. Blood 95:368-74
Kaul, D K; Liu, X D (1999) Rate of deoxygenation modulates rheologic behavior of sickle red blood cells at a given mean corpuscular hemoglobin concentration. Clin Hemorheol Microcirc 21:125-35
Barabino, G A; Liu, X D; Ewenstein, B M et al. (1999) Anionic polysaccharides inhibit adhesion of sickle erythrocytes to the vascular endothelium and result in improved hemodynamic behavior. Blood 93:1422-9
Kaul, D K; Liu, X D; Nagel, R L et al. (1998) Microvascular hemodynamics and in vivo evidence for the role of intercellular adhesion molecule-1 in the sequestration of infected red blood cells in a mouse model of lethal malaria. Am J Trop Med Hyg 58:240-7
Hirsch, R E; Jelicks, L A; Wittenberg, B A et al. (1997) A first evaluation of the natural high molecular weight polymeric Lumbricus terrestris hemoglobin as an oxygen carrier. Artif Cells Blood Substit Immobil Biotechnol 25:429-44
Kaul, D K; Fabry, M E; Costantini, F et al. (1995) In vivo demonstration of red cell-endothelial interaction, sickling and altered microvascular response to oxygen in the sickle transgenic mouse. J Clin Invest 96:2845-53
Kaul, D K; Chen, D; Zhan, J (1994) Adhesion of sickle cells to vascular endothelium is critically dependent on changes in density and shape of the cells. Blood 83:3006-17

Showing the most recent 10 out of 14 publications